Epithelial Breast Cancer Flashcards

1
Q

Describe the anatomy of a breast.

A

These consist mainly of adipose, connective and epithelial tissues. The layer of adipose tissue protects a large number of lobules, connected by ducts that lead towards the nipple. There has to be a more scientific word for nipple.

The breast also contains a large number of lymph nodes to protect against infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the blood supply to the breast.

A

The internal mammary artery and vein branch off from the axillary artery and vein which run above the breast. The largely overlapping blood vessels have two primary branches running down either side with smaller offshoot vessels in the direction of the centre.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the role of the lymphatic system?

A

Lymph ducts drain interstitial fluid that carries white blood cells from the breast tissues into lymph nodes.

Lymph nodes filter harmful bacteria and play a key role in fighting off infection.

All major nodes are tested for metastatic growth if cancer is suspected.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How is the breast affected by the endocrine system?

A

The breast is extensively affected by various hormones.
Oestrogens and progesterone from the ovaries,
Prolactin and GH from the pituitary
and corticosteroid, progestone and oestrogen (converted from androgen in transit by aromatase) from the adrenal gland.

This is highly relevant to the cancers of the breast as they often become dependent upon such signalling, especially oestrogen signalling.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the epidemiology of breast cancer.

A

Breast cancer is the most common lethal neoplasm in women, accounting for 25-30% of all female cancer; 1 out of 7 women will have BC over their lifetime

The incidence of male breast cancer is about 1 % of all breast cancer cases and causes 0.1% of male cancer deaths per year.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the non-hereditary risk factors specific for breast cancer?

A
  • Family history of breast cancer
  • Being age 55 or older
  • Previous breast cancer
Personal Estrogen-Related Risks
Increased risks:
• Early menstruation (before 12yrs old)
• Oral contraceptives
• Child bearing (no children or 1st child after 30 yrs old)
• Late menopause (after 55yrs old)
• Long-term HRT (more than 5 years)

Decreased risks:
• Breastfeeding - 12+ months – decreased risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the hereditary risk factors for breast cancer?

A

• 5-10% of breast cancer is caused by inherited
genetic mutations

• 25% of Familial Breast Cancer (FBC) occurs in
women younger than 30 years old

• 2-5% of BC is caused by inherited mutations
in BRCA 1 and BRCA 2 genes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is the progression of breast cancer classified?

A

With the TNM staging system;

The Tumour Diameter increase
Lymph node involvement
Metastasis to distant tissues (primarily bone, liver, lungs and brain).

Other than that they are classed by the classical stage 1 (confined to original site, node negative), stage 2 (node positive), stage three (spread to superficial structures of chest wall) and stage four (advanced metastasis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What non-cancerous conditions are often mistaken for breast cancer?

A

 Fibrocystic changes: Lumpiness, thickening and swelling, often associated with a woman’s period

 Cysts: Fluid-filled lumps can range from very tiny to about the size of an egg

 Fibroadenomas: A solid, round, rubbery lump that moves under skin when touched, occurring mainly in young women

 Infections: The breast will likely be red, warm, tender and lumpy

 Microcalcifications: Tiny deposits of calcium can appear anywhere in a breast and often show up on a mammogram

 Trauma: a blow to the breast or a bruise can cause a lump

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is mammography?

A

Use of a low-dose x-ray system to examine breasts

 Digital mammography replaces x-ray film by solid-state detectors that convert x-rays into electrical signals. These signals are used to produce images that can be displayed on a computer screen (similar to digital cameras)

 Mammography can show changes in the breast up to two years before a physician can feel them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What mammography screening habits are recommended?

A

 Biannually or annually in 40-49 y/o

 Annually in >50 y/o

 15% relative risk reduction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the three biopsy techniques?

A

Fine needle aspiration (FNA) - Diagnostic and therapeutic (cystic lesions)

Stereotactic needle biopsy (SNB) - an ultrasoundguided and mammogram-directed needle aspiration biopsy of breast tissue

Excision biopsy - an excision of a breast lump through a small cut. Usually no other breast tissue or lymph nodes (glands) are removed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is oestrogen signalling received by breast epithelial cells?

A

Oestrogen is recognised by one of the two of oestrogen receptor - membrane (mostly GPCRs) and soluble nuclear receptor: as a steroid hormone it able to diffuse through the plasma membrane into the cell.

The nuclear receptors directly interact with the transcription machinery to facilitate many functions, including stimulating proliferation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the Erb-B receptor family?

A

These have multiple names each, but are closely related RTKs.

EGFR, HER1, ErbB1 binds a variety of growth factor ligands mostly og the EGF family, and notably is the only one to bind EGF itself. It is capable of homodimerising and heterodimerising with Her2.

ErbB2, HER2, neu has no known ligand binding activity. It serves only to heterodimerise with activated ErbB receptors to stimulate the signal.

ErbB3, HER3 has ligand binding activity, binding HRG, but no RTK activity, so relies on heterodimerisation with HER2.

ErbB4, HER4 binds various ligands, mostly of the neuregulin family, and can transduce its own signal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Which ErbB receptor is the most commonly mutated in breast cancer?

A

ErbB2/HER2/neu, despite its lack of ligand binding capacity it is amplified in 20-30% of breast cancer. This event occurs at early-stage of breast cancer development and is associated with increased disease recurrence and worse prognosis.

This receptor regulates signalling pathways which control cell growth, proliferation and survival. Overexpression also correlates with oestrogen receptor null mutation.

As such it is targeted by trastuzumab, which prevents dimerisation and so activation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What therapy targets the oestrogen receptor?

A

Tamoxifen. This is a Selective Estrogen Receptor Mediator (SERM), acting as an antagonist (bind with no effect, comp. inhib.) in some tissues and an agonist (stimulated response) in others.

Tamoxifen binds the ER in the same site as oestrogen, but does not induce the conformation change required to recruit the co-activators.

Tamoxifen selectively inhibits the proliferative oestrogen signalling in the breast, so is used to prevent breast cancer and also treat it in ER-positive breast cancer.

17
Q

What gene is involved in familial breast cancer?

A

BRCA1, a tumor suppressing TF located on chromosome 17q21.

This regulates cell proliferation, homologous recombination and repairs double-strand breaks in DNA.

Over 100 different mutations are associated with the
truncation of BRCA 1 protein. Women with an abnormal BRCA1 gene have up to an 60% risk of developing breast cancer by age 90.

BRCA2 is also involved, but was much more recently discovered so less is known about it.

18
Q

With what proteins might BRCA1 interact with in its DNA damage repair capacity?

A

In its DNA damage repair function it interacts with RAD51 and BASC (BRCA1-associated genome surveillance complex).

19
Q

What is BRCA2?

A

BRCA2 a transcription factor located on chromosome 13q12. Its function is repair of chromosomal damage with an important role in the error-free repair of DNA double-stranded breaks.

20
Q

What does BRCA2 mutation cause?

A

BRCA2 mutations are usually insertions or deletions of a
small number of DNA base pairs.

Increased risk of breast cancer, as well as prostate, laryngeal and endometrial cancer, but lower incidence of ovarian cancer.

People who have two mutated copies of the BRCA2 gene develop Fanconi anemia and are prone to leukemia.

21
Q

What is the domain organisation of BRCA1?

A

1,863 amino acids total.

Ring finger domain (E2F interaction)
Two consecutive NLS (p53, Rb, SW1/SNF)
DNA binding domain (BASC and RAD51 interaction, TF activity)
Serine Cluster Domain (phosphorylable regulatory region. ATM, CHK2, CDK2 interaction)
BRCT domains (pY binding domain interacts with Pol II, p300, HDACs, Rb, p53, BACH Ubiq Lig)
22
Q

How is BRCA1 regulated?

A

DSBs activate the ATM and ATR pathways leading to activation of CHK2. This phosphorylates BRCA1, stimulating it to act upon a great many proteins.

Phosphorylation of BRCA1 can occur at a huge variety of locations within the SCD, which finely controls its ability to bind a variety of proteins and thus shift its function to a specific niche.

23
Q

What are the main effects of BRCA1 activation?

A

Chromatin remodelling, signalling to SW1/SNF and HDACs opens up the chromatin to allow homologous recombination which it stimulates via the BASC complex and FANCD2.

Stimulates CHK1 which inhibits cell cycle progression (G1/S and G2/M) while the DNA is damaged. Signallling to PLK1, Rb and p53 reinforces this effect.

Stimulated BARD1 to ubiquitinate a variety of targets to mark them for degradation - wide reaching effects.

It also interacts with Xist to mediate lyonisation.

24
Q

What are some of the effects of BARD1?

A

BRCA1 complexes with this and an E3 ligase at the Ring finger domain, causing it to ubiquitinate many things as a multi-component complex, some regulatory (H2AX, FANCD2, p53 etc) and some to stimulate degradation.

25
Q

What is the BRCA1/BRCA2 signalling complex?

A

Upon DSB signalling a vast multi-enzyme complex forms to mediate all of this signalling, composed of ATM, BRCA1/2, BARD1, BLM, FANCD2 and the BASC complex. Between them this enables this complex to mediate a vast number of effects to mediate the majority of the DNA damage repair signalling.

26
Q

How is Myc affected in breast cancer?

A

Myc signalling amplification is one of the main alterations in breast cancer cells. However, this is not found in early tumours.

It is instead involved in the progression of the tumour, especially in the formation of infiltrated ductal carcinoma and poorly differentiated tumours.

27
Q

How is p53 affected in breast cancer?

A

p53 activity is often downregulated due to changes in MDM2 activity sequestering it in the cytoplasm.

Mutations in the p53 gene itself are less common, except in sporadic breast cancer and Li-Fraumani syndrome.

It is used as a prognosticant, node negative patients with p53 mutations have much lower chance of long-term survival and increased incidence of recurrence following surgery.

28
Q

What are the main prognostic factors in breast cancer?

A
Lymph node status
Degree of tumour differentiation
Hormone receptor status (ER and PR)
ErbB2 expression
p53 mutations
29
Q

What are the main therapies used to treat breast cancer?

A
Surgical removal of the tumour
Chemotherapy
Endocrine Directed (Hormone) Therapy
Biological agents
 Trastuzumab (AKA Herceptin, anti-ErbB2)
 Bevacizumab (AKA Avastin, anti-VEGF)